ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,558Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 331

$359K Total Retail Price of All Prescriptions

Rank: 44 out of 331

305 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
4% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 305 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

9% of this provider’s 305 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 7,520 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$29 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
RANITIDINE HCL 960 511 1 4
METFORMIN HCL 538 355 2 2
SIMVASTATIN 518 310 3 1
TIZANIDINE HCL 503 224 4 117
TRAMADOL HCL 415 185 5 23
OMEPRAZOLE 392 238 6 5
HYDROCHLOROTHIAZIDE 300 188 7 10
ENALAPRIL MALEATE 286 167 8 3
LOSARTAN POTASSIUM 278 211 9 8
LEVOTHYROXINE SODIUM 275 180 10 9
GABAPENTIN 275 166 10 7
TRAMADOL HCL-ACETAMINOPHEN 242 129 12 18
FUROSEMIDE 227 134 13 15
OXYCODONE-ACETAMINOPHEN 221 99 S2 14 78
GLIPIZIDE 220 151 15 19
ZOLPIDEM TARTRATE 200 92 16 22
CARVEDILOL 190 150 17 33
NABUMETONE 190 138 17 25
SYNTHROID 181 107 19 11
DICLOFENAC POTASSIUM 165 70 20 32
LISINOPRIL 164 101 21 13
GEMFIBROZIL 159 74 22 65
AMLODIPINE BESYLATE 159 137 22 6
ALENDRONATE SODIUM 153 115 24 17
ATENOLOL 150 99 25 12
MECLIZINE HCL 132 98 26 51
METOPROLOL TARTRATE 119 72 27 16
ISOSORBIDE MONONITRATE ER 118 78 28 31
PLAVIX 116 94 29 46
EVISTA 115 87 30 61
PENTOXIFYLLINE 101 70 31 53
LOSARTAN-HYDROCHLOROTHIAZIDE 99 82 32 14
RAMIPRIL 97 77 33 52
AZITHROMYCIN 97 40 33 29
METOCLOPRAMIDE HCL 90 43 35 109
INSULIN SYRINGE 89 60 36 37
TAMSULOSIN HCL 89 70 36 34
CLOPIDOGREL 88 63 38 39
DOXAZOSIN MESYLATE 86 75 39 30
ASPIRIN EC 85 63 40 27
SERTRALINE HCL 84 53 41 28
ADVAIR DISKUS 78 51 42 92
CEPHALEXIN 77 48 43 133
CLOTRIMAZOLE-BETAMETHASONE 76 38 44 43
PREDNISONE 74 35 45 68
FAMOTIDINE 73 58 46 50
LORATADINE 68 34 47 93
QVAR 68 30 47 184
SULFAMETHOXAZOLE-TRIMETHOPRIM 61 24 49 107
DIOVAN 58 32 50 69
HUMULIN R 57 47 51 208
THEOPHYLLINE ANHYDROUS 56 16 52 111
HUMULIN 70-30 56 33 52 45
CLOBETASOL PROPIONATE 54 20 54 147
SINGULAIR 54 32 54 58
ISOSORBIDE DINITRATE 50 48 56 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 11, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.